Lexaria Bioscience Corp Cash Flow-to-Debt Ratio
Lexaria Bioscience Corp cash flow-to-debt ratio. Lexaria Bioscience Corp (LEXX) has a Cash Flow-to-Debt Ratio of -3.74x as of May 2026, meaning its operating cash flow of $-1.64 Million could theoretically repay -4% of its total liabilities ($437.09K) in one year. Check Lexaria Bioscience Corp (LEXX) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Lexaria Bioscience Corp (2005–2025)
Cash flow-to-debt ratio of Lexaria Bioscience Corp from 2005 to 2025. Historical debt coverage capacity for Lexaria Bioscience Corp across 21 annual periods. Check Lexaria Bioscience Corp (LEXX) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Lexaria Bioscience Corp Cash Flow-to-Debt Ratio by Year (2005–2025)
Lexaria Bioscience Corp cash flow-to-debt ratio by year from 2005 to 2025. Year-by-year debt coverage analysis for Lexaria Bioscience Corp. For the full cash flow conversion analysis, see LEXX operating cash flow.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -6.65x | $-10.45 Million | $1.57 Million | ▼ -62.0% |
| 2024 | -4.10x | $-4.96 Million | $1.21 Million | ▲ +71.8% |
| 2023 | -14.56x | $-5.88 Million | $403.91K | ▲ +39.9% |
| 2022 | -24.22x | $-4.88 Million | $201.44K | ▼ -23.4% |
| 2021 | -19.63x | $-3.99 Million | $203.26K | ▼ -159.3% |
| 2020 | -7.57x | $-2.62 Million | $345.98K | ▲ +53.5% |
| 2019 | -16.29x | $-3.01 Million | $184.51K | ▲ +71.8% |
| 2018 | -57.70x | $-2.52 Million | $43.64K | ▼ -244.7% |
| 2017 | -16.74x | $-1.55 Million | $92.35K | ▼ -1113.1% |
| 2016 | -1.38x | $-660.86K | $478.88K | ▲ +94.9% |
| 2015 | -27.23x | $-1.50 Million | $55.12K | ▼ -12607.3% |
| 2014 | 0.22x | $321.00K | $1.47 Million | ▲ +0.0% |
| 2013 | 0.22x | $321.00K | $1.47 Million | ▼ -1.1% |
| 2012 | 0.22x | $321.00K | $1.46 Million | ▲ +171.8% |
| 2011 | 0.08x | $135.94K | $1.68 Million | ▲ +8.9% |
| 2010 | 0.07x | $109.84K | $1.48 Million | ▲ +127.3% |
| 2009 | -0.27x | $-330.34K | $1.21 Million | ▼ -489.6% |
| 2008 | -0.05x | $-36.40K | $788.18K | ▼ -163.8% |
| 2007 | 0.07x | $29.04K | $400.98K | ▲ +166.7% |
| 2006 | -0.11x | $-218.56K | $2.01 Million | ▲ +99.2% |
| 2005 | -13.72x | $-153.38K | $11.18K | — |